ES2187783T3 - Derivados de indolina utiles como antagonistas del receptor 5-ht-2c. - Google Patents

Derivados de indolina utiles como antagonistas del receptor 5-ht-2c.

Info

Publication number
ES2187783T3
ES2187783T3 ES97928224T ES97928224T ES2187783T3 ES 2187783 T3 ES2187783 T3 ES 2187783T3 ES 97928224 T ES97928224 T ES 97928224T ES 97928224 T ES97928224 T ES 97928224T ES 2187783 T3 ES2187783 T3 ES 2187783T3
Authority
ES
Spain
Prior art keywords
antagonists
receiver
derivatives useful
indoline derivatives
rent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97928224T
Other languages
English (en)
Spanish (es)
Inventor
Steven Mark Smithklin Bromidge
Ian Thomson Smithkline Forbes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of ES2187783T3 publication Critical patent/ES2187783T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES97928224T 1996-06-20 1997-06-16 Derivados de indolina utiles como antagonistas del receptor 5-ht-2c. Expired - Lifetime ES2187783T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9612883.0A GB9612883D0 (en) 1996-06-20 1996-06-20 Novel compounds

Publications (1)

Publication Number Publication Date
ES2187783T3 true ES2187783T3 (es) 2003-06-16

Family

ID=10795575

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97928224T Expired - Lifetime ES2187783T3 (es) 1996-06-20 1997-06-16 Derivados de indolina utiles como antagonistas del receptor 5-ht-2c.

Country Status (33)

Country Link
US (1) US6369060B1 (en:Method)
EP (1) EP0912554B1 (en:Method)
JP (1) JP2000512306A (en:Method)
KR (1) KR20000022045A (en:Method)
CN (1) CN1229408A (en:Method)
AP (2) AP9801410A0 (en:Method)
AR (1) AR008243A1 (en:Method)
AT (1) ATE228514T1 (en:Method)
AU (1) AU718597B2 (en:Method)
BG (1) BG103089A (en:Method)
BR (1) BR9709911A (en:Method)
CA (1) CA2258240A1 (en:Method)
CO (1) CO4890847A1 (en:Method)
CZ (1) CZ420598A3 (en:Method)
DE (1) DE69717449T2 (en:Method)
DZ (1) DZ2250A1 (en:Method)
EA (1) EA001780B1 (en:Method)
ES (1) ES2187783T3 (en:Method)
GB (1) GB9612883D0 (en:Method)
HU (1) HUP9903439A3 (en:Method)
ID (1) ID19433A (en:Method)
IL (1) IL127417A0 (en:Method)
MA (1) MA24214A1 (en:Method)
NO (1) NO985972D0 (en:Method)
NZ (1) NZ333229A (en:Method)
OA (1) OA10944A (en:Method)
PE (1) PE86698A1 (en:Method)
PL (1) PL330796A1 (en:Method)
SK (1) SK282706B6 (en:Method)
TR (1) TR199802661T2 (en:Method)
TW (1) TW382015B (en:Method)
WO (1) WO1997048699A1 (en:Method)
ZA (1) ZA975415B (en:Method)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043650A2 (en) * 1998-02-25 1999-09-02 Smithkline Beecham Plc Process(es) for the preparation of 6-trifluoromethyl-indoline derivatives
GB0019950D0 (en) * 2000-08-12 2000-09-27 Smithkline Beecham Plc Compounds
AU2002346507A1 (en) 2001-11-28 2003-06-10 Pharmacia And Upjohn Company Benzazepine derivatives and their use as 5-ht ligands
CA2475254A1 (en) * 2002-03-04 2003-09-18 Pharmacia & Upjohn Company Pyridinyloxy derivatives as 5-ht receptor ligands
KR101062376B1 (ko) * 2008-04-10 2011-09-06 한국화학연구원 신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물
WO2010083044A1 (en) 2009-01-16 2010-07-22 Massachusetts Institute Of Technology Diagnosis and treatment of autism spectrum disorders
ES2847883T3 (es) 2010-12-17 2021-08-04 Glaxo Group Ltd Uso de inhibidores de LP-PLA2 en el tratamiento y prevención de enfermedades oculares
WO2014046544A1 (en) 2012-09-21 2014-03-27 Aapa B.V. Substituted 3-heteroaryloxy-3-(hetero)aryl-propylamines as serotonin transporter and serotonin ht2c receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001333A1 (en) * 1987-08-07 1989-02-23 The Australian National University IMIDAZO[1,2-b]PYRIDAZINES
NZ254785A (en) 1992-08-20 1995-09-26 Smithkline Beecham Plc Heterocyclically-condensed indoles and medicaments
GB9313913D0 (en) * 1993-07-06 1993-08-18 Smithkline Beecham Plc Novel compounds
FI973205L (fi) 1995-02-02 1997-10-01 Smithkline Beecham Plc Indolijohdannaisia 5-HT-reseptoriantagonisteina
GB9607219D0 (en) * 1996-04-04 1996-06-12 Smithkline Beecham Plc Novel compounds
GB9615767D0 (en) * 1996-07-26 1996-09-04 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
AU718597B2 (en) 2000-04-20
EP0912554A1 (en) 1999-05-06
CN1229408A (zh) 1999-09-22
NO985972L (no) 1998-12-18
PL330796A1 (en) 1999-06-07
US6369060B1 (en) 2002-04-09
AR008243A1 (es) 1999-12-29
HUP9903439A2 (en) 2000-07-28
EA199900043A1 (ru) 1999-06-24
SK282706B6 (sk) 2002-11-06
HUP9903439A3 (en) 2002-12-28
CO4890847A1 (es) 2000-02-28
TW382015B (en) 2000-02-11
ATE228514T1 (de) 2002-12-15
GB9612883D0 (en) 1996-08-21
AP745A (en) 1999-04-28
ZA975415B (en) 1998-12-21
BR9709911A (pt) 1999-08-10
BG103089A (en) 1999-09-30
AP9801410A0 (en) 1998-12-31
AU3260297A (en) 1998-01-07
NO985972D0 (no) 1998-12-18
OA10944A (en) 2003-02-27
PE86698A1 (es) 1999-01-28
NZ333229A (en:Method) 2000-01-28
CA2258240A1 (en) 1997-12-24
DZ2250A1 (fr) 2002-12-18
EP0912554B1 (en) 2002-11-27
KR20000022045A (ko) 2000-04-25
DE69717449D1 (de) 2003-01-09
DE69717449T2 (de) 2003-10-02
MA24214A1 (fr) 1997-12-31
EA001780B1 (ru) 2001-08-27
AP9701037A0 (en) 1997-07-31
ID19433A (id) 1998-07-09
IL127417A0 (en) 1999-10-28
JP2000512306A (ja) 2000-09-19
WO1997048699A1 (en) 1997-12-24
TR199802661T2 (xx) 1999-03-22
SK175298A3 (en) 1999-05-07
CZ420598A3 (cs) 1999-06-16

Similar Documents

Publication Publication Date Title
ES2054872T3 (es) Nuevos derivados de acido bencimidazolin-2-oxo-1-carboxilico utiles como antagonistas de los receptores 5-ht.
ES2153907T3 (es) Compuestos espiro tetraciclicos, procedimiento para su preparacion y su uso como antagonistas del receptor 5ht1d.
ES2151652T3 (es) Derivados de indol como antagonistas del receptor 5ht.
AR001332A1 (es) Nuevos compuestos antagonistas de la taquicinina, proceso para obtenerlos y composiciones farmaceuticas que los contienen.
MX9300842A (es) Antagonistas de endotelina de sulfonamida.
ECSP003531A (es) Derivados de purina
ES2116594T3 (es) Ansamicinas biciclicas y su uso como agentes antitumorales.
ES2132223T3 (es) Derivados de indol condensados en calidad de antagonistas del receptor 5-ht4.
BR0013427A (pt) Compostos heteropolicìclicos e seus usos como antagonistas no receptor de glutamato metabotrópico
ES2113368T3 (es) Antagonistas de serotonina.
ES2171884T3 (es) Compuestos de quinazolina.
DK0725782T3 (da) A1-adenosin-receptor-agonister og antiagonister
ES2184797T3 (es) Uso de antagonistas de serotonina (5ht3) para el tratamiento de la fibromialgia.
ES2164657T3 (es) Derivados aza-biciclicos puenteados como antagonistas de la sustancia p.
ECSP941156A (es) 3 bencilaminometil piperidinas substituidas con heteroarilamino y heteroarilsulfonamido y compuestos afines
ECSP003713A (es) Derivados de purina
ECSP003712A (es) Derivados de la purina
NZ326608A (en) Adenosine and xanthine derivative as a1 adenosine receptor agonists and antagonists
ES2196063T3 (es) Utilizacion de agentes antagonistas competitivos de progesterona para la preparacion de medicamentos destinados al tratamiento de hemorragias uterinas disfuncionales.
AR006119A1 (es) Compuestos de quinoxalinadionas uso de los mismos para la fabricacion de un medicamento, compuestos de quinoxalinas para producirlos y procedimiento parala preparacion de los mismos
ES2062374T3 (es) Heteroarilpiperazinas, agentes antipsicoticos.
ES2084339T3 (es) Tetrahidropiridinas e hidroxipiperidinas sustituidas utiles como agentes para el sistema nervioso central.
ES2038707T3 (es) Procedimiento para la obtencion de enantiomeros (+) y (-) de derivados de la 3,4-dihidro-2h-(1)-benzopiran-3-amina.
ES2152682T3 (es) Derivados de indolina utiles como antagonistas del receptor 5ht-2c.
ES2060818T3 (es) Derivados de indol, benzofurano y benzotiofeno sustituidos como inhibidores de la 5-lipooxigenasa.